Seminars in Liver Disease

LinksSchließen

Referenz

Harrison SA, Bashir MR, Guy CD. et al.
Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial.

Lancet 2019;
394 (10213): 2012-2024

Bibliographische Angaben herunterladen

Aufrufen in: